IRIS
IANNETTA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.479
EU - Europa 825
AS - Asia 194
SA - Sud America 16
OC - Oceania 14
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 5
Totale 3.545
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.454
IE - Irlanda 304
IT - Italia 274
CN - Cina 107
SE - Svezia 85
GB - Regno Unito 47
FR - Francia 35
KR - Corea 27
DE - Germania 26
CA - Canada 25
FI - Finlandia 15
AU - Australia 14
BR - Brasile 12
TR - Turchia 12
BE - Belgio 11
HK - Hong Kong 8
PK - Pakistan 8
IR - Iran 7
IQ - Iraq 6
NL - Olanda 6
ZA - Sudafrica 5
EU - Europa 4
IN - India 4
RU - Federazione Russa 4
VN - Vietnam 4
CH - Svizzera 3
CL - Cile 3
GH - Ghana 3
PL - Polonia 3
UA - Ucraina 3
UZ - Uzbekistan 3
GR - Grecia 2
JP - Giappone 2
KG - Kirghizistan 2
NG - Nigeria 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
BG - Bulgaria 1
ES - Italia 1
ID - Indonesia 1
MD - Moldavia 1
MK - Macedonia 1
RO - Romania 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 3.545
Salva come PNG Salva come JPEG
Città #
Fairfield 366
Chandler 292
Wilmington 259
Dublin 227
Houston 183
Medford 157
Woodbridge 137
Ashburn 134
Cambridge 119
Seattle 116
Rome 114
Ann Arbor 84
New York 81
Beijing 72
Lawrence 72
San Diego 47
Seoul 27
Milan 26
Menlo Park 21
Toronto 21
Engelhard 17
London 15
Creede 14
Falls Church 12
Palo Alto 12
Adelaide 11
Brussels 11
Kilburn 11
Helsinki 9
Wuhan 8
Redwood City 7
Umuarama 7
Council Bluffs 6
Dearborn 6
Hong Kong 6
Lappeenranta 6
Monte Vista 6
Amsterdam 5
Guangzhou 5
Istanbul 5
Mülheim 5
Najaf 5
Naples 5
Norwalk 5
Port Elizabeth 5
Ridgeland 5
St. George 5
Hangzhou 4
La Veta 4
Minturno 4
Nanjing 4
Paris 4
Rochester 4
Santa Clara 4
Segrate 4
Sialkot 4
Vasto 4
Accra 3
Arak 3
Chengdu 3
Chicago 3
Florence 3
Lahore 3
Prescot 3
San Cesareo 3
Shanghai 3
Vicenza 3
Albano Laziale 2
Alfonsine 2
Amantea 2
Bologna 2
Campofranco 2
Cesano Maderno 2
Chester 2
Clearwater 2
Cologno Monzese 2
Colorado Springs 2
Dong Ket 2
Durham 2
Erzurum 2
Frankfurt am Main 2
Greenwood 2
Karaman 2
Lagos 2
Lecce 2
Melbourne 2
Modena 2
Mountain View 2
Notre Dame 2
Nuremberg 2
Ottawa 2
Ponte Buggianese 2
Reggio Calabria 2
Rio de Janeiro 2
San Francisco 2
Serra dos Dourados 2
Southwark 2
Tappahannock 2
Tokyo 2
Turin 2
Totale 2.905
Salva come PNG Salva come JPEG
Nome #
Reactivation of Hepatitis B Virus With Immune-Escape Mutations After Ocrelizumab Treatment for Multiple Sclerosis 218
Low testosterone levels and high estradiol to testosterone ratio are associated with hyperinflammatory state and mortality in hospitalized men with COVID-19 169
Depressive and anxiety symptoms in patients with SARS-CoV2 infection 145
Chikungunya Outbreak in the Republic of the Congo, 2019—Epidemiological, Virological and Entomological Findings of a South-North Multidisciplinary Taskforce Investigation 94
Long-Term SARS-CoV-2 Infection Associated with Viral Dissemination in Different Body Fluids Including Bile in Two Patients with Acute Cholecystitis 91
Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab 85
Long-term SARS-CoV-2 infection associated with viral dissemination in different body fluids Including bile in two patients with acute cholecystitis 85
Cryptic HBV replicative activity is frequently revealed in anti-HBC-positive/hbsag-negative patients with HIV infection by highly sensitive molecular assays, and can be predicted by integrating classical and novel serological HBV markers 78
In patients with severe COVID-19, the profound decrease in the peripheral Bblood T-cell subsets is correlated with an increase of QuantiFERON-TB Gold Plus indeterminate rates and reflecting a reduced interferon-gamma production 60
Archetype and rearranged non-coding control regions in urothelial bladder carcinoma of immunocompetent individuals 56
Human polyomavirus JC replication and non-coding control region analysis in multiple sclerosis patients under natalizumab treatment 55
Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study 55
Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in {SARS}-{CoV}-2 infected patients: a single center study 53
Poor CD4/CD8 ratio recovery in HBcAb-positive HIV patients with worse immune status is associated with significantly higher CD8 cell numbers 51
Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients 49
Conventional Dendritic Cells and Slan+ Monocytes During HIV-2 Infection 49
Altered antigen-presenting cells during HIV-1 infection 48
Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon 47
Cell-associated {HIV} cross-presentation by plasmacytoid dendritic cells is potentiated by noncognate {CD}8$mathplus$ T cell preactivation 47
T-cell responses to SARS-CoV-2 in Multiple Sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-Spike antibody titers 46
Blood myeloid dendritic cells and slanDC in antiretroviral therapy-Suppressed HIV-infected patients 45
Persistent detection of dengue virus RNA in vaginal secretion of a woman returning from Sri Lanka to Italy, April 2017 45
Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae 45
B- and T-Cell Responses After {SARS}-{CoV}-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications 45
Natalizumab affects T-Cell phenotype in multiple sclerosis: Implications for JCV reactivation 44
Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections 44
Azithromycin Shows Anti-Zika Virus Activity in Human Glial Cells 44
Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection 44
Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients 44
Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients 44
In vivo release of alpha-defensins in plasma, neutrophils and CD8 T-lymphocytes of patients with HIV infection 43
Early and Polyantigenic CD4 T Cell Responses Correlate with Mild Disease in Acute COVID-19 Donors 41
Case report: Delayed diagnosis of congenital malaria by plasmodium vivax in a newborn of an Eritrean woman with varicella infection 41
In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-γ T cell response 41
HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA After Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort 41
B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications 40
Hiv-2 infection in a migrant from gambia: The history of the disease combined with phylogenetic analysis revealed the real source of infection 40
High CD169 monocyte/lymphocyte ratio reflects immunophenotype disruption and oxygen need in COVID-19 patients 40
Longitudinal Evaluation of the QuantiFERON-TB Gold Plus Assay in Hospitalized COVID-19 Patients with a First Indeterminate Result: Resolution of Inflammation and Restoration of T-Lymphocyte Counts and Interferon-Gamma Production 36
Validation of the T-Lymphocyte Subset Index (TLSI) as a Score to Predict Mortality in Unvaccinated Hospitalized COVID-19 Patients 36
Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters 36
HIV-associated progressive multifocal leukoencephalopathy: Current perspectives 36
HIV-associated progressive multifocal leukoencephalopathy: Longitudinal study of JC virus non-coding control region rearrangements and host immunity 36
Evaluation of S-RBD and high specificity ACE-2-binding antibodies on SARS-CoV-2 patients after six months from infection 36
Severe Plasmodium ovale malaria complicated by acute respiratory distress syndrome in a young Caucasian man 35
JC Virus-DNA Detection Is Associated with CD8 Effector Accumulation in Peripheral Blood of Patients with Multiple Sclerosis under Natalizumab Treatment, Independently from JC Virus Serostatus 35
Viral Hemorrhagic Fevers Other than Ebola and Lassa 34
Prolonged detection of dengue virus RNA in the semen of a man returning from Thailand to Italy, january 2018 34
Unexpected human cases of cutaneous anthrax in Latium region, Italy, August 2017: integrated human-animal investigation of epidemiological, clinical, microbiological and ecological factors 34
Pacemaker lead endocarditis due to multidrug-resistant Corynebacterium striatum detected with sonication of the device 34
Imported severe malaria and risk factors for intensive care: A single-centre retrospective analysis 33
Primary retroperitoneal abscesses due to Rhodococcus equi in a patient with severe nephrotic syndrome: successful antibiotic treatment with linezolid and tigecycline 33
Role of sonication in the microbiological diagnosis of implant-associated infections: beyond the orthopedic prosthesis 33
Sonication of explanted cardiac implants improves microbial detection in cardiac device infections 33
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 33
High CD169 Monocyte/Lymphocyte Ratio Reflects the Immunophenotyping Disruption and Predicts Oxygen Need in COVID-19 Patients 33
Human Arboviral Infections in Italy: Past, Current, and Future Challenges 32
Early Atherosclerosis in HIV Infected Subjects on Suppressive Antiretroviral Treatment: Role of Osteoprotegerin 32
ZIKV infection induces an inflammatory response but fails to activate types I, II, and III IFN response in human PBMC 32
Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical hiv-associated atherosclerosis 30
NMR-based metabolomic approach to study urine samples of chronic inflammatory rheumatic disease patients 30
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April-December 2021 in Italy 29
Higher levels of osteoprotegerin and immune activation/immunosenescence markers are correlated with concomitant bone and endovascular damage in HIV-suppressed patients 29
Diagnostic value of JC polyomavirus viruria, viremia, serostatus and microRNA expression in multiple sclerosis patients undergoing immunosuppressive treatment 29
Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab 28
Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients 27
Persistent detection of Zika virus RNA in semen for six months after symptom onset in a traveller returning from Haiti to Italy, February 2016 27
Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection 26
Severe bloodstream infection due to KPC-producer e coli in a renal transplant recipient treated with the double-carbapenem regimen and analysis of in vitro synergy testing a case report 24
Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing 23
Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: a three-year observational cohort study 23
Diagnostic Value of JC Polyomavirus Viruria, Viremia, Serostatus and microRNA Expression in Multiple Sclerosis Patients Undergoing Immunosuppressive Treatment 22
JCPyV NCCR analysis in PML patients with different risk factors: exploring common rearrangements as essential changes for neuropathogenesis 22
Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia 22
Neuro-Axonal Damage and Alteration of Blood–Brain Barrier Integrity in COVID-19 Patients 20
Impact of IFN-Free and IFN-Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan-DC, and Activated T Lymphocyte Dynamics during HCV Infection. 19
Study of methicillin-resistant Staphylococcus aureus (MRSA) carriage in a population of HIV-negative migrants and HIV-infected patients attending an outpatient clinic in Rome 19
Hepatitis B-related hepatic flare during immune reconstitution syndrome after antiretroviral treatment initiation in an HBV surface antigen-positive patient with HIV: viroimmunological and histological characterization 18
Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses 18
First Evidence of Pathogenic HERV-W Envelope Expression in T Lymphocytes in Association with the Respiratory Outcome of COVID-19 Patients 18
Which is the best PML risk stratification strategy in natalizumab-treated patients affected by multiple sclerosis? 17
Role of HBcAb Positivity in Increase of HIV-RNA Detectability after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Months 48 Results of a Multicenter Italian Cohort 16
Increased Mild Vaccine-Related Side Effects and Higher Specific Antibody Titers in Health Care Workers with Previous SARS-CoV-2 Infection after the mRNA BNT162b2 Vaccine 16
Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study) 16
Sonication technique improves microbiological diagnosis in patients treated with antibiotics before surgery for prosthetic joint infections 16
Admission eGFR predicts in-hospital mortality independently of admission glycemia and C-peptide in patients with type 2 diabetes mellitus and COVID-19 15
Expression profile of HERVs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of COVID-19 severity 15
Circulation of sars-cov-2 variants in central Italy: spike variability characterization by deep-sequencing. 14
Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplant Recipients: A Retrospective Italian Cohort Study in Tor Vergata University Hospital, Rome 14
Humoral Response after Two Doses of BNT162b2 mRNA Vaccine Has a Role in Predicting Response after Three Doses That Is Related to Plasma HIV Viremia and Nadir CD4+ Cell Count in HIV-Positive Patients 14
Lactococcus garvieae endocarditis in a patient with colonic diverticulosis: First case report in Italy and review of the literature 14
Doravirine/lamivudine/tenofovir disoproxil fumarate-induced hypertriglyceridemia in a newly diagnosed AIDS patient 13
An in-depth characterization of VOCs circulation by using NGS analysis of the Spike protein. 13
Persistence of ZIKV-RNA in the cellular fraction of semen is accompanied by a surrogate-marker of viral replication. Diagnostic implications for sexual transmission 12
null 12
The transactivation of endogenous retroviruses correlates with HIV reservoir, lymphocytes activation and low CD4 count in virologically suppressed patients 10
Prevalence of HDV infection in Central Italy has remained stable across the last two decades with dominance of sub-genotypes 1 and characterized by elevated viral replication 10
Remdesivir Influence on SARS-CoV-2 RNA Viral Load Kinetics in Nasopharyngeal Swab Specimens of COVID-19 Hospitalized Patients: A Real-Life Experience 10
Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage. 9
HDV replicative activity parallels the production of the three HBsAg forms (Large, Middle and Small HBsAg) and its pathogenetic impact is exacerbated by concomitant HBV replication 8
Totale 3.835
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.589
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.589
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201925 0 0 0 0 0 0 0 0 0 0 12 13
2019/2020394 11 8 6 9 8 12 9 9 8 7 301 6
2020/2021883 74 6 110 8 34 237 175 79 38 83 24 15
2021/20221.035 97 122 55 130 9 77 65 85 74 65 33 223
2022/2023974 96 50 54 67 100 229 98 102 78 13 44 43
2023/2024586 70 23 62 89 50 112 35 46 16 78 5 0
Totale 3.919